Relmada Therapeutics, Inc. Common Stock — Institutional Ownership

Which tracked institutions hold RLMD, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

15
Funds holding
$102778272
Total value held
Buying
12 added/new · 2 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Janus Henderson Group Plc $76892206 11063862 NEW BUY
2 Blackrock, Inc. $8975269 1289550 +22047 +1.74%
3 Goldman Sachs Group Inc $5034439 723339 +554039 +327.25%
4 Ameriprise Financial Inc $3711475 533258 -1386841 -72.23%
5 State Street Corp $2484998 357040 +36220 +11.29%
6 Morgan Stanley $1381303 198463 +136106 +218.27%
7 Sei Investments Co $1159633 166614 NEW BUY
8 Northern Trust Corp $1097829 157734 -7719 -4.67%
9 Bank Of America Corp /De/ $876549 125941 +100601 +397.00%
10 Barclays Plc $619114 88953 NEW BUY
11 Alti Global, Inc. $222546 31975 Held
12 Bank Of Nova Scotia $212976 30600 NEW BUY
13 Citigroup Inc $108839 22534 +22532 +1126600.00%
14 Royal Bank Of Canada $1000 95 NEW BUY
15 Amalgamated Financial Corp. $96 3567 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.